| Invested through |
|
|---|---|
| Asset Classes | Listed equity |
| Impact strategy | Impact Equities and Bonds |
| Bloomberg ticker | ISRG US |
| ISIN code | US46120E6023 |
| Industry group | Health Care Equipment & Services |
| Aligned with SDGs |
Intuitive Surgical was founded in 1995 and is the pioneer and global technology leader in robotic-assisted, minimally invasive surgery. The company develops, manufactures and markets the da Vinci surgical system, through which it aims to make surgery more effective, less invasive and easier on surgeons, patients and their families.
Da Vinci's main clinical applications are general, gynaecologic, urologic, (cardio)thoracic and head & neck (TORS) surgery. Especially general surgery is growing at a quick pace. This category includes hernia repair, colorectal surgery (treating cancerous conditions of the lower digestive system), cholecystectomy (surgical removal of gall bladder) and bariatric surgery (treating patients for morbid obesity and its secondary effects, such as diabetes).
The company's revenues can be broken down into three categories: systems, instruments & accessories and services. A large part of total revenues can be considered recurring, i.e. instruments & accessories, services and the operating lease part of systems. Intuitive Surgical is headquartered in Sunnyvale, California.
Investment rationale
Robotic surgery enables surgeons to conduct their procedures with less impact on the patient: greater consistency, reduced pain and discomfort, faster recovery times, smaller incisions and reduced blood loss are some of the main benefits. All this causes patients to recover more quickly from surgical procedures, meaning patients can return home quicker leading to better availability of hospital beds. For surgeons, Intuitive Surgical's da Vinci systems enhance the possibilities to commit surgery, leading to better patient outcomes. It gives the physician greater visualisation, dexterity and precision and makes long surgeries more comfortable to perform.
Alignment with Triodos Transitions:
100% of revenues is aligned with the Wellbeing Transition. The contribution to the Wellbeing Transition comes from 100% of revenues related to the impact objective Health Care.